March 5, 2026 / biostate.AI
Training Biomedical AI with Real Clinical Data
Dear Biostate AI investors, followers, and collaborators,
Building biomedical AI starts with real clinical partnerships.
Today, Biostate works with more than 30 hospitals, nonprofit organizations, and clinical partners across the United States, India, and China. Through these collaborations, we have access to over 100,000 consented human samples across multiple disease areas. We continue to expand these partnerships.
United States
In the United States, our collaborators include the Accelerated Cure Project on multiple sclerosis, Massachusetts General Hospital on melanoma, and Weill Cornell Medical School on leukemia.
India
In India, we work with Narayana Health on coronary artery disease, Tata Memorial Hospital on leukemia, and Cloud 9 Hospitals on prenatal disorders.
China
In China, we have established a joint venture with Kindstar Global, one of the largest clinical laboratory companies in the country, to advance research in leukemia, lupus, and oral cancer. We also collaborate with Xinqiao Hospital, Peking University Hospital, and Wuhan University across various disease programs.
Each collaboration gives us access not only to biological samples, but also to carefully curated clinical context, including diagnoses, longitudinal outcomes, and demographic data. This context allows models to move beyond simple pattern recognition and toward meaningful clinical insight.
Thank you for being part of this journey. Simply reply to this email if you would like to talk.
Best regards,
The Biostate AI Team